Immune checkpoint inhibitors in SARS-COV-2 infected cancer patients: the spark that ignites the fire?

Since December 2019, a novel coronavirus disease (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), initially reported un Wuhan, China, rapidly spread in other 114 countries worldwide, becoming pandemic.1

Source: Lung Cancer - May 9, 2020 Category: Cancer & Oncology Authors: Vincenzo Di Noia, Alessandro D ’Aveni, Michela Squadroni, Giordano Berett, Giovanni Luca Ceresoli Source Type: research